Literature DB >> 1646878

Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering.

M T Lamy-Freund1, S Schreier, R M Peitzsch, W F Reed.   

Abstract

Quasielastic light scattering measurements of amphotericin B (AB):deoxycholate (DOC) preparations provided information about particle size and aggregation as a function of concentration. The data allowed the time dependence of the aggregation to be followed and indicated that the initial rates of the change in average equivalent hydrodynamic diameter increased with decreasing concentration. The results extend the model proposed by Lamy-Freund and co-workers, which describes AB:DOC systems as consisting of AB:DOC mixed aggregates co-existing with pure DOC micelles. Although the AB:DOC aggregates are unstable at all concentrations studied, the rate of aggregation increases by three orders of magnitude as the concentration is reduced from 20 mM (DOC concentration) to the concentration region of DOC micellization. These results are in agreement with the different distribution of AB and DOC in the body of experimental animals, and may be of relevance for the understanding of the serious toxic effects of AB.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646878     DOI: 10.1002/jps.2600800314

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

2.  Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index.

Authors:  F Gaboriau; M Chéron; C Petit; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

3.  Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form.

Authors:  B Baas; K Kindt; A Scott; J Scott; P Mikulecky; S C Hartsel
Journal:  AAPS PharmSci       Date:  1999

4.  Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.

Authors:  Celeste Alvarez; Dae Hwan Shin; Glen S Kwon
Journal:  Pharm Res       Date:  2016-05-19       Impact factor: 4.200

5.  Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

6.  Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes.

Authors:  P Legrand; E A Romero; B E Cohen; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

7.  Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicity.

Authors:  Yuri Svirkin; Jaeweon Lee; Richard Marx; Seongkyu Yoon; Nelson Landrau; Md Abul Kaisar; Bin Qin; Jin H Park; Khondoker Alam; Darby Kozak; Yan Wang; Xiaoming Xu; Jiwen Zheng; Benjamin Rivnay
Journal:  Asian J Pharm Sci       Date:  2022-06-08       Impact factor: 9.273

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.